Form 4 for WGS GeneDx Holdings Corp.
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-02 · accession 0001209191-23-027332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-04 | 2023-05-02 | WGS | PFENNIGER RICHARD C JR | Dir | M - OptEx | $0.00 | +30.3K | 30.3K | New | $0 |
| D | 2023-05-04 | 2023-05-02 | WGS | PFENNIGER RICHARD C JR | Dir | M - OptEx | $0.00 | -30.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-02 | M | A | 30,303 | $0.00 | 30,303 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2023-05-02 | M | D | 30,303 | $0.00 | 0 | D | — · — to — | 60,606 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) The underlying shares vest as to 1/3 of the total award annually beginning on May 2, 2023 until fully vested, subject to the Reporting Person continuing to provide services to the Issuer on the applicable vesting date. |